Ignite Creation Date:
2024-05-06 @ 3:45 PM
Last Modification Date:
2025-12-16 @ 10:16 PM
Study NCT ID:
NCT04745442
Status:
None
Last Update Posted:
2021-02-09 00:00:00
First Post:
2021-02-08 00:00:00
Brief Title:
Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19
Sponsor:
Maimónides Biomedical Research Institute of Córdoba
Organization:
Maimónides Biomedical Research Institute of Córdoba
Study Overview
Official Title:
Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19
Status:
None
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Pilot clinical trial, with a marketed drug -natural component of human plasma-, not approved for this indication, single-center, exploratory, open, randomized, controlled, to study the efficacy and safety of human Antithrombin in patients with confirmed COVID-19 disease and criteria high risk to develop SARS.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None